top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Advance in the Treatment of Pediatric Leukemia
Advance in the Treatment of Pediatric Leukemia
Autore Handgretinger Rupert
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 online resource (300 p.)
Soggetto topico Chemistry
Research & information: general
Soggetto non controllato 5-azacitidine
ABCC4
acute lymphoblastic leukemia
acute myeloid leukemia
acute pancreatitis
ADC
advances
ALL
allogeneic stem cell transplantation
alternative donors
AML
antibody
antibody-drug conjugate
B-ALL
BCL11B
BCP-ALL
bispecific T-cell engager (BiTE)
CD19
CFTR
childhood acute lymphoblastic leukemia
children
chronic myeloid leukemia
CML
conditioning regimen
COVID-19
diagnosis
DUX4
evolution of CAR T cells
Fc-engineering
FDA-approved CAR products
future directions of CAR T cell therapy
genome
hematopoietic stem cell transplantation
IKZF1
immunizations
immunotherapy
juvenile myelomonocytic leukemia
L-asparaginase
leukemia
limitations and complications of CAR T cell therapy
low-risk ALL
lymphoblastic leukemia
minimal residual disease
myelodysplastic/myeloproliferative disorders
n/a
NOTCH1
NUTM1
other extramedullary relapse
PAX5
pediatric
pediatric leukemia
Ph-like
polymorphism
prognosis
RAS signaling
risk-stratified treatment
SNV
T-ALL
targeted therapy
TcR versus CAR
TRAIL
transcriptome
treatment
treatment related toxicity
tyrosine kinase inhibitor
xenograft
ZNF384
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910576878903321
Handgretinger Rupert  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Recent Developments in Cancer Systems Biology
Recent Developments in Cancer Systems Biology
Autore Sinha Raghu
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 online resource (272 p.)
Soggetto topico Medicine and Nursing
Soggetto non controllato acute myeloid leukemia
bioinformatics
biomarker
Boolean model
brain-tumor-initiating cell (BTIC)
breast
cancer
cancer genomics
cancer progression
cancer stem cells
cancer systems biology
circulating miR-1246
clinical trials
CNV
computational methods
diagnostic biomarker
differential expression
docking
drug repurposing
drug resistance
Elk-1
Ets
ETS
Ets-1
experimental model systems
genomics
glioma
glycomics
glycosaminoglycan binding
knockdown
lung adenocarcinoma
lung adenocarcinoma (LUAD)
lung cancer
lung squamous cell carcinoma (LUSC)
metabolomics
metagenomics
microarray
n/a
network
next-generation sequencing
non-small-cell lung cancer
omics
optical genome mapping
ovarian
pancreatic cancer
patient survival
patient-derived organoids
patient-derived xenografts
PEA3
personalized medicine
PI3K-Akt signaling pathways
prognosis
prognostic biomarker
protein interactome
proteomics
renal cancers
risk group
Sestrin2
signature
single-cell sequencing
SNV
solid tumors
stem cell
survival
systems biology
TargetScan
TCGA
transcriptomics
triple-negative breast cancer
UBE2C
virtual screening
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557768503321
Sinha Raghu  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui